Last updated on February 2017

Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma


Brief description of study

The purpose of this study is to see if an experimental drug, called copanlisib is effective and safe in treating adult participants with cholangiocarcinoma, when used in combination with gemcitabine and cisplatin.

Clinical Study Identifier: NCT02631590

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Thomas George, M.D.

University of Florida
Gainesville, FL United States
  Connect »

Richard D. Kim, M.D.

H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL United States
  Connect »